Chiral Pharmaceutical Intermediaries Obtained by Reduction of 2-Halo-1-(4-substituted phenyl)-ethanones Mediated by <i>Geotrichum candidum</i> CCT 1205 and 
                        <i>Rhodotorula glutinis</i>  CCT 2182

<table>Pharmaceutical useful ethanolamines.</table>

Enzyme Research

fig2

Figure 2

Figure 2: Chiral Pharmaceutical Intermediaries Obtained by Reduction of 2-Halo-1-(4-substituted phenyl)-ethanones Mediated by <i>Geotrichum candidum</i> CCT 1205 and 
                        <i>Rhodotorula glutinis</i>  CCT 2182 

Figure 2 | Chiral Pharmaceutical Intermediaries Obtained by Reduction of 2-Halo-1-(4-substituted phenyl)-ethanones Mediated by Geotrichum candidum CCT 1205 and 
                        Rhodotorula glutinis  CCT 2182 

Enzyme Research

Chiral Pharmaceutical Intermediaries Obtained by Reduction of 2-Halo-1-(4-substituted phenyl)-ethanones Mediated by Geotrichum candidum CCT 1205 and Rhodotorula glutinis CCT 2182

Figure 2